Embecta EMBC
NASDAQ EMBC
$5.23 -0.24 (-4.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Embecta (EMBC) Non-Current Deferred Tax Liability (2021 - 2026)

Embecta (EMBC) posted Non-Current Deferred Tax Liability of $63.4 million for Q1 2026, up 3.93% sequentially from $61.0 million in Q4 2025, and up 8.38% YoY from $58.5 million in Q1 2025.

Embecta (EMBC) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

Embecta has reported Non-Current Deferred Tax Liability for 6 years, with the latest figure at $63.4 million in Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 8.38% year-over-year to $63.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.4 million (up 8.38% YoY) and the FY2025 annual result came in at $62.6 million, up 15.71% from the prior year.
  • Non-Current Deferred Tax Liability rose to $63.4 million in Q1 2026 per EMBC's latest filing, from $61.0 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $63.5 million in Q2 2025 and troughed at $31.4 million in Q1 2022.
  • A 5-year average of $50.3 million and a median of $54.1 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability surged 82.28% in 2023, then retreated 22.81% in 2024.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $33.3 million in 2022, then surged by 82.28% to $60.7 million in 2023, then declined by 8.4% to $55.6 million in 2024, then gained by 9.71% to $61.0 million in 2025, then advanced by 3.93% to $63.4 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $63.4 million, $61.0 million, and $62.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Embecta 305.26 Mn 87.06 Mn 153.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 115.10 Mn
Jun 30, 2026 115.10 Mn
Mar 31, 2026 63.40 Mn
Mar 31, 2026 63.40 Mn
Dec 31, 2025 61.00 Mn
Dec 31, 2025 61.00 Mn
Sep 30, 2025 62.60 Mn
Sep 30, 2025 62.60 Mn
Jun 30, 2025 63.50 Mn
Jun 30, 2025 63.50 Mn
Mar 31, 2025 58.50 Mn
Mar 31, 2025 58.50 Mn
Dec 31, 2024 55.60 Mn
Dec 31, 2024 55.60 Mn
Sep 30, 2024 54.10 Mn
Sep 30, 2024 54.10 Mn
Jun 30, 2024 39.20 Mn
Jun 30, 2024 39.20 Mn
Mar 31, 2024 36.20 Mn
Mar 31, 2024 36.20 Mn